BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23934388)

  • 1. Perspectives of the relationship between IL-7 and autoimmune diseases.
    Wang XS; Li BZ; Hu LF; Wen PF; Zhang M; Pan HF; Ye DQ
    Clin Rheumatol; 2013 Dec; 32(12):1703-9. PubMed ID: 23934388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of interleukin-22 in autoimmune diseases.
    Pan HF; Li XP; Zheng SG; Ye DQ
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):51-7. PubMed ID: 22906768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping and identification of autoimmunity genes.
    Encinas JA; Kuchroo VK
    Curr Opin Immunol; 2000 Dec; 12(6):691-7. PubMed ID: 11102774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin D and autoimmunity. Second part: Clinical aspects].
    Schoindre Y; Terrier B; Kahn JE; Saadoun D; Souberbielle JC; Benveniste O; Amoura Z; Piette JC; Cacoub P; Costedoat-Chalumeau N
    Rev Med Interne; 2012 Feb; 33(2):87-93. PubMed ID: 22209319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases.
    Mirzaei R; Zamani F; Hajibaba M; Rasouli-Saravani A; Noroozbeygi M; Gorgani M; Hosseini-Fard SR; Jalalifar S; Ajdarkosh H; Abedi SH; Keyvani H; Karampoor S
    J Neuroimmunol; 2021 Sep; 358():577640. PubMed ID: 34224949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protooncogenes and autoimmunity.
    Rapoport M; Mor A; Bistritzer T; Ramot Y; Levi O; Slavin S; Wysenbeek A
    Isr J Med Sci; 1997 Apr; 33(4):262-6. PubMed ID: 9347876
    [No Abstract]   [Full Text] [Related]  

  • 7. IL-18 in inflammatory and autoimmune disease.
    Sedimbi SK; Hägglöf T; Karlsson MC
    Cell Mol Life Sci; 2013 Dec; 70(24):4795-808. PubMed ID: 23892891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cells and autoimmune disease.
    Wu L; Van Kaer L
    Curr Mol Med; 2009 Feb; 9(1):4-14. PubMed ID: 19199937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulatory B cells in human autoimmune diseases].
    Miyagaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(5):390-7. PubMed ID: 26725860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity.
    Kunz M; Ibrahim SM
    Mediators Inflamm; 2009; 2009():979258. PubMed ID: 19884985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
    Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
    Genes Immun; 2013 Mar; 14(2):67-82. PubMed ID: 23190644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
    Zhang Q; Vignali DA
    Immunity; 2016 May; 44(5):1034-51. PubMed ID: 27192568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-13: A promising therapeutic target for autoimmune disease.
    Mao YM; Zhao CN; Leng J; Leng RX; Ye DQ; Zheng SG; Pan HF
    Cytokine Growth Factor Rev; 2019 Feb; 45():9-23. PubMed ID: 30581068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of IL-35 in inflammatory autoimmune diseases.
    Su LC; Liu XY; Huang AF; Xu WD
    Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential route of Th17/T
    Karri SK; Sheela A
    Br J Biomed Sci; 2017 Jan; 74(1):8-15. PubMed ID: 28074676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferon in organ-targeted autoimmune and inflammatory diseases.
    Crow MK
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S5. PubMed ID: 21303493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PD-1/PD-Ls pathway and autoimmune diseases.
    Dai S; Jia R; Zhang X; Fang Q; Huang L
    Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases.
    Wu H; Chen Y; Zhu H; Zhao M; Lu Q
    Front Immunol; 2019; 10():2305. PubMed ID: 31611879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?
    Simoni Y; Diana J; Ghazarian L; Beaudoin L; Lehuen A
    Clin Exp Immunol; 2013 Jan; 171(1):8-19. PubMed ID: 23199318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.